Biomea Fusion Statistics
Total Valuation
Biomea Fusion has a market cap or net worth of $440.32 million. The enterprise value is $306.13 million.
Market Cap | 440.32M |
Enterprise Value | 306.13M |
Important Dates
The last earnings date was Thursday, May 2, 2024, after market close.
Earnings Date | May 2, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Biomea Fusion has 35.94 million shares outstanding. The number of shares has increased by 21.31% in one year.
Shares Outstanding | 35.94M |
Shares Change (YoY) | +21.31% |
Shares Change (QoQ) | +0.33% |
Owned by Insiders (%) | 25.14% |
Owned by Institutions (%) | 87.27% |
Float | 19.47M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.25 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.84, with a Debt / Equity ratio of 0.08.
Current Ratio | 5.84 |
Quick Ratio | n/a |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.90% and return on invested capital (ROIC) is -93.69%.
Return on Equity (ROE) | -69.90% |
Return on Assets (ROA) | -60.40% |
Return on Capital (ROIC) | -93.69% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.16M |
Employee Count | 110 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.79% in the last 52 weeks. The beta is -0.35, so Biomea Fusion's price volatility has been lower than the market average.
Beta (1Y) | -0.35 |
52-Week Price Change | -62.79% |
50-Day Moving Average | 13.18 |
200-Day Moving Average | 14.30 |
Relative Strength Index (RSI) | 50.36 |
Average Volume (30 Days) | 1,009,993 |
Short Selling Information
The latest short interest is 13.97 million, so 38.86% of the outstanding shares have been sold short.
Short Interest | 13.97M |
Short Previous Month | 13.82M |
Short % of Shares Out | 38.86% |
Short % of Float | 71.76% |
Short Ratio (days to cover) | 14.20 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -137.16M |
Pretax Income | -127.27M |
Net Income | -127.27M |
EBITDA | -122.55M |
EBIT | -127.27M |
Earnings Per Share (EPS) | -$3.57 |
Balance Sheet
The company has $145.29 million in cash and $11.09 million in debt, giving a net cash position of $134.20 million or $3.73 per share.
Cash & Cash Equivalents | 145.29M |
Total Debt | 11.09M |
Net Cash | 134.20M |
Net Cash Per Share | $3.73 |
Equity / Book Value | 135.31M |
Book Value Per Share | 3.76 |
Working Capital | 122.31M |
Cash Flow
In the last 12 months, operating cash flow was -$104.58 million and capital expenditures -$499,000, giving a free cash flow of -$105.08 million.
Operating Cash Flow | -104.58M |
Capital Expenditures | -499,000 |
Free Cash Flow | -105.08M |
FCF Per Share | -$2.93 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Biomea Fusion does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.31% |
Shareholder Yield | -21.31% |
Earnings Yield | -28.90% |
FCF Yield | -23.86% |
Analyst Forecast
The average price target for Biomea Fusion is $46.80, which is 282.35% higher than the current price. The consensus rating is "Buy".
Price Target | $46.80 |
Price Target Difference | 282.35% |
Analyst Consensus | Buy |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |